Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Merville

Showing results (111-120 of 138) with videos related to

Pageof 14
Sort By:
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|August 23, 2020
Is recipient's body mass index a determinant of short term complications in early renal transplantation?V Queruel, R Kabore, A Guillaume, et al.
Transplantation Proceedings|March 15, 2000
Cytomegalovirus infection in kidney allograft recipients is followed by a prolonged expansion of gammadelta T lymphocytesP Merville, J Déchanet, F Bergé, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 9, 2000
Mechanisms of persistent NF-kappa B activity in the bronchi of an animal model of asthmaF Bureau, S Delhalle, G Bonizzi, et al.
Cancer Gene Therapy|March 4, 2000
Cytosine deaminase suicide gene therapy for peritoneal carcinomatosisM Bentires-Alj, A C Hellin, C Lechanteur, et al.
Revue Des Maladies Respiratoires|June 6, 2007
[Sarcoidosis and renal insufficiency]A Izadifar, J M Vernejoux, C Raherison, et al.
Prostaglandins, Leukotrienes, and Essential Fatty Acids|January 23, 2003
Pharmacological evaluation of the novel thromboxane modulator BM-567 (II/II). Effects of BM-567 on osteogenic sarcoma-cell-induced platelet aggregationX de Leval, V Benoit, J Delarge, et al.
Open Forum Infectious Diseases|February 23, 2023
Cytomegalovirus DNAemia Requiring (Val)Ganciclovir Treatment for More Than 8 Weeks Is a Key Factor in the Development of Antiviral Drug ResistanceM Acquier, B Taton, S Alain, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|October 5, 2011
High incidence of anticytomegalovirus drug resistance among D+R- kidney transplant recipients receiving preemptive therapyL Couzi, S Helou, T Bachelet, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|October 10, 2013
Hepatitis E virus infection as a new probable cause of de novo membranous nephropathy after kidney transplantationB Taton, K Moreau, S Lepreux, et al.
European Radiology|May 19, 2015
Embolization of renal arteries before transplantation in patients with polycystic kidney disease: a single institution long-term experienceF Petitpierre, F Cornelis, L Couzi, et al.
Pageof 14

Showing results (111-120 of 138) with videos related to

Sort By:
Pageof 14
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|August 23, 2020
Is recipient's body mass index a determinant of short term complications in early renal transplantation?V Queruel, R Kabore, A Guillaume, et al.
Transplantation Proceedings|March 15, 2000
Cytomegalovirus infection in kidney allograft recipients is followed by a prolonged expansion of gammadelta T lymphocytesP Merville, J Déchanet, F Bergé, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 9, 2000
Mechanisms of persistent NF-kappa B activity in the bronchi of an animal model of asthmaF Bureau, S Delhalle, G Bonizzi, et al.
Cancer Gene Therapy|March 4, 2000
Cytosine deaminase suicide gene therapy for peritoneal carcinomatosisM Bentires-Alj, A C Hellin, C Lechanteur, et al.
Revue Des Maladies Respiratoires|June 6, 2007
[Sarcoidosis and renal insufficiency]A Izadifar, J M Vernejoux, C Raherison, et al.
Prostaglandins, Leukotrienes, and Essential Fatty Acids|January 23, 2003
Pharmacological evaluation of the novel thromboxane modulator BM-567 (II/II). Effects of BM-567 on osteogenic sarcoma-cell-induced platelet aggregationX de Leval, V Benoit, J Delarge, et al.
Open Forum Infectious Diseases|February 23, 2023
Cytomegalovirus DNAemia Requiring (Val)Ganciclovir Treatment for More Than 8 Weeks Is a Key Factor in the Development of Antiviral Drug ResistanceM Acquier, B Taton, S Alain, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|October 5, 2011
High incidence of anticytomegalovirus drug resistance among D+R- kidney transplant recipients receiving preemptive therapyL Couzi, S Helou, T Bachelet, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|October 10, 2013
Hepatitis E virus infection as a new probable cause of de novo membranous nephropathy after kidney transplantationB Taton, K Moreau, S Lepreux, et al.
European Radiology|May 19, 2015
Embolization of renal arteries before transplantation in patients with polycystic kidney disease: a single institution long-term experienceF Petitpierre, F Cornelis, L Couzi, et al.
Pageof 14